Published in Infect Immun on February 01, 2003
Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology (2009) 2.22
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology (2008) 1.60
Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection. PLoS One (2015) 1.43
Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun (2003) 1.05
Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS One (2010) 1.05
Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II. J Immunol (2011) 1.02
Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase. Infect Immun (2010) 0.97
TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. PLoS One (2013) 0.93
NF-kappaB activation during acute Helicobacter pylori infection in mice. Infect Immun (2007) 0.92
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A. Helicobacter (2011) 0.92
A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cells. PLoS One (2009) 0.91
Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol (2010) 0.90
Helicobacter pylori-pulsed dendritic cells induce H. pylori-specific immunity in mice. Helicobacter (2008) 0.90
Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog (2007) 0.90
Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta}. Clin Vaccine Immunol (2009) 0.89
Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis. Infect Immun (2004) 0.88
Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization. PLoS One (2013) 0.84
Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity. PLoS One (2013) 0.84
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance. J Immunol Res (2015) 0.81
Vaccinating against Helicobacter pylori in the developing world. Gut Microbes (2013) 0.80
Establishment of Helicobacter pylori infection model in Mongolian gerbils. World J Gastroenterol (2004) 0.77
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 10.65
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest (1997) 4.62
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12
Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med (2000) 4.09
Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut (1991) 3.82
Inducible nitric oxide synthase: what difference does it make? J Clin Invest (1997) 3.72
T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol (1997) 3.61
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A (1995) 3.53
Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut (1997) 3.39
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology (1996) 3.00
Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol (1996) 2.77
Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun (1998) 2.71
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med (1998) 2.70
Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol (2000) 2.54
Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology (1997) 2.18
Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun (1999) 2.14
Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut (1998) 2.07
Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol (1999) 1.99
Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J Immunol (2002) 1.80
Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun (1999) 1.69
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect Immun (1999) 1.49
Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol (1999) 1.43
Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect Immun (2002) 1.37
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine (1997) 1.26
Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J Infect Dis (2001) 1.22
IL-12 exacerbates helminth-mediated corneal pathology by augmenting inflammatory cell recruitment and chemokine expression. J Immunol (1997) 1.16
Further development of the Helicobacter pylori mouse vaccination model. Vaccine (2000) 1.15
On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol (1997) 1.13
Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol (1997) 1.11
Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur J Immunol (1997) 1.08
Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol Immunol (2000) 1.06
Inducible nitric oxide synthase mediates early epithelial repair of porcine ileum. Am J Physiol Gastrointest Liver Physiol (2002) 1.05
Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling. Infect Immun (2001) 1.04
Interleukin-12 an integral cytokine in the immune response. Life Sci (1996) 1.04
Effect of nitric oxide on Helicobacter pylori morphology. J Infect Dis (1999) 0.94
The immune response against Helicobacter pylori--a direct linkage to the development of gastroduodenal disease. Microbes Infect (2000) 0.92
Characterization of lymphocytic subsets and cytokine production in gastric biopsy samples from Helicobacter pylori patients. Scand J Gastroenterol (1998) 0.91
Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants. Microbes Infect (2000) 0.90
Helicobacter pylori gastritis: a Th1 mediated disease? J Biotechnol (2000) 0.88
Involvement of nitric oxide and prostaglandins in gastroprotection induced by bacterial lipopolysaccharide. Scand J Gastroenterol (1998) 0.85
Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol (2004) 1.75
Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Helicobacter (2005) 1.70
Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant (2006) 1.64
Helicobacter infection: pathogenesis. Curr Opin Gastroenterol (2004) 1.50
Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.49
Maintenance of Helicobacter pylori cultures in agar stabs. Helicobacter (2010) 1.46
Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect Immun (2002) 1.37
Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J Immunol (2006) 1.23
Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J Infect Dis (2003) 1.20
Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J Biol Chem (2010) 1.16
Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun (2003) 1.05
Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr (2007) 1.05
Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol (2009) 1.03
Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis. Infect Immun (2003) 1.02
Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice. Infect Immun (2003) 1.01
Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis. Antimicrob Agents Chemother (2003) 0.99
Regulation of murine dendritic cell immune responses by Helicobacter felis antigen. Infect Immun (2006) 0.99
Pyogenic granuloma of the colon in children. J Pediatr Gastroenterol Nutr (2006) 0.98
Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis. J Immunol (2004) 0.97
Absence of catalase reduces long-term survival of Helicobacter pylori in macrophage phagosomes. Helicobacter (2004) 0.95
Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis. J Leukoc Biol (2005) 0.94
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A. Helicobacter (2011) 0.92
Genome sequences of 65 Helicobacter pylori strains isolated from asymptomatic individuals and patients with gastric cancer, peptic ulcer disease, or gastritis. Pathog Dis (2013) 0.91
Helicobacter pylori-induced disruption of monolayer permeability and proinflammatory cytokine secretion in polarized human gastric epithelial cells. Infect Immun (2013) 0.90
Immunity, inflammation, and vaccines for Helicobacter pylori. Helicobacter (2014) 0.90
Helicobacter pylori inflammation and immunity. Helicobacter (2002) 0.89
Isolation and purification of colon lamina propria dendritic cells from mice with colitis. Cytotechnology (2005) 0.87
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation. Biol Blood Marrow Transplant (2004) 0.87
Partial protection against Helicobacter pylori in the absence of mast cells in mice. Infect Immun (2009) 0.86
IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori. PLoS One (2013) 0.84
CD25+ T cells induce Helicobacter pylori-specific CD25- T-cell anergy but are not required to maintain persistent hyporesponsiveness. Eur J Immunol (2008) 0.84
Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization. PLoS One (2013) 0.84
Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection. Clin Immunol (2009) 0.81
Vaccination as a method of preventing Helicobacter pylori-associated gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.80
Laboratory maintenance of Helicobacter species. Curr Protoc Microbiol (2012) 0.79
Differential effects of Sendai virus infection on mediator synthesis by mesangial cells from two mouse strains. Kidney Int (2003) 0.79
Fms-like tyrosine kinase 3-based immunoprophylaxis against infection is improved by adjuvant treatment with anti-interleukin-10 antibody. J Infect Dis (2005) 0.78
In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN. J Immunol (2006) 0.78
CpG-induced IFNgamma expands TLR4-specific IL-18 responses in vivo. Cell Immunol (2007) 0.77
Interleukin 12 and interferon-gamma synthetic deficiency is associated with dendritic cell cytopenia after cardiac surgery. Shock (2005) 0.77
Helicobacter pylori and Gastric Inflammation: Role of MUC1 Mucin. J Pediatr Biochem (2012) 0.75
Recent advances that favor development of a vaccine for Helicobacter pylori infection. Ped Health (2008) 0.75
Laboratory maintenance of helicobacter species. Curr Protoc Microbiol (2006) 0.75
Lack of genetic influence on the innate inflammatory response to helicobacter infection of the gastric mucosa. Front Immunol (2012) 0.75
Helicobacter pylori vaccines: is DNA the answer? Helicobacter (2006) 0.75
Helicobacter pylori in children and adolescents. Adolesc Med Clin (2004) 0.75
Introduction: First International Symposium on: pediatric inflammatory bowel disease: September 16-18, 2003; Irvington, Virginia, U.S.A. J Pediatr Gastroenterol Nutr (2005) 0.75
Analysis of innate immune responses in a model of IgA nephropathy induced by Sendai virus. Contrib Nephrol (2007) 0.75